Metraipolis › archive › dc_b00cf47d97e4

CAR-T cell therapy for autoimmune diseases: current clinical trial landscape and the next wave of development — Europe PMC PMID:42292395

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42292395
DOI
10.3389/fimmu.2026.1853170
License (as archived)
solo-consultazione
Archived
2026-11-01T04:46:20.096Z
SHA-256 of the archived text
e318544f3aff4de1d8e10be714437d6fca0017782a5c80964ff544ed79118be2
Stable URL of this page
https://metraipolis.com/documento/dc_b00cf47d97e4

How to cite

CAR-T cell therapy for autoimmune diseases: current clinical trial landscape and the next wave of development — Europe PMC PMID:42292395 — Europe PMC (en), https://europepmc.org/article/MED/42292395 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b00cf47d97e4 (Metraipolis archive dc_b00cf47d97e4, sha256 e318544f3aff4de1d8e10be714437d6fca0017782a5c80964ff544ed79118be2)
BibTeX
@misc{dcb00cf47d97e4,
  title = {CAR-T cell therapy for autoimmune diseases: current clinical trial landscape and the next wave of development — Europe PMC PMID:42292395},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42292395},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b00cf47d97e4; sha256 e318544f3aff4de1d8e10be714437d6fca0017782a5c80964ff544ed79118be2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42292395. Agents can read the archived copy with the MCP tool read_document.